Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New York On Verge Of Setting Limits For 1,4-Dioxane In Cosmetic Products

Executive Summary

Cosmetic cleansing products containing 1,4-dioxane at levels above 1 part per million would be unlawfully marketed in New York beginning in 2023 under legislation passed by the state’s legislature in June. Governor Andrew Cuomo reportedly is reviewing the bill.

You may also be interested in...



Cosmetics News In Brief: NY Slaps Limit On Cosmetic 1,4-Dioxane Content; J&J Talc Drama; IFF Merger

Suspected trace carcinogen 1,4-dioxane must be limited to 2 parts per million in personal cleansing products sold in New York after 31 December 2022, and 1 ppm one year later, under recently enacted legislation. More cosmetics news in brief.

Industry Presses NY Governor Not To Sign 1,4-Dioxane Bill, Warns Of Far-Reaching Consequences

Market disruptions, “dramatically” higher prices, lost jobs and negative health consequences all are possible if legislation passed in New York in June to reduce 1,4-dioxane exposures is enacted in its current form, trade organizations say. Cleaning product industry advocates are leading the opposition, but personal-care manufacturers stand to be impacted as well.

US And California Authorities Have 1,4-Dioxane Under Review; Ripple Effects Possible, Attorney Says

Potentially present at trace levels in personal-care products manufactured with ethoxylated materials, 1,4-dioxane is getting regulatory looks from multiple angles at the US state and federal levels. Chemicals law expert Lynn Bergeson of Bergeson & Campbell discusses potential implications for cosmetics industry players.

Related Content

Topics

UsernamePublicRestriction

Register

RS149024

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel